Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System

The recent application of targeted immunotherapy has greatly improved the clinical outcomes of patients with lung adenocarcinoma (LUAD), but drug resistance continues to emerge, and to evaluate and to improve patient prognosis are arduous. The diagnostic and prognostic value of N6-methyladenosine (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chundi, Li, Huayao, Ma, Wenzhe, Zhang, Qiming, Liu, Cun, Liu, Lijuan, Zhuang, Jing, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428682/
https://www.ncbi.nlm.nih.gov/pubmed/36061307
http://dx.doi.org/10.1155/2022/7519838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428682/
https://www.ncbi.nlm.nih.gov/pubmed/36061307
http://dx.doi.org/10.1155/2022/7519838

Ejemplares similares